abstract |
DISCLOSED ARE NOVEL COMPOUND OF FORMULA I, AS DEFINED HEREIN AND THEIR USE AS PHARMACEUTICALLY ACTIVE COMPOUNDS FOR REDUCING BLOOD GLUCOSE, AND/OR TREATING ONE OR MORE OF TYPE II DIABETES, DISTURBANCES OF LIPID AND CARBOHYDRATE METABOLISM, ARTERIOSCLEROTIC MANIFESTATIONS, AND INSULIN RESISTANCE. |